Published on 25th April 2013
A new infographic from Bioquell illustrates some of the factors associated with inconsistent performance of biological indicators (BIs) used to assess hydrogen peroxide vapour (HPV) bio-decontamination cycles.
Published on 18th February 2013
Threats against civilian and private security vehicles using airborne contaminants, such as car-jacking and kidnap attempts, can now be protected against following the launch of the new Bioquell LEAF system.
Published on 31st December 2012
Johns Hopkins Hospital Study Shows Hydrogen Peroxide Vapor Technology Reduces Patient Risk of Superbug Infection.
Findings indicate Bioquell system should be used in high-risk settings to maximize patient safety.
Published on 10th October 2012
The benefits of Bioquell’s hydrogen peroxide vapour (HPV) technology have been featured in a series of independent assessments at this year’s Infection Prevention Society (IPS) conference
Published on 1st October 2012
A new tool in the armoury for infection prevention and control professionals has been launched at IPS 2012 – the Bioquell ICE-pod.
Published on 16th August 2012
A bundle of infection control measures using the latest hydrogen peroxide vapour (HPV) disinfection technology has significantly reduced the incidence of nosocomial MRSA and Acinetobacter baumannii in one of Europe’s leading burns units.
Published on 18th June 2012
To meet the challenges of sterility testing, a revolutionary new fully integrated hydrogen peroxide vapour (HPV) workstation called the Bioquell QUBE has been launched at this year’s Achema event in Frankfurt.
Published on 11th April 2012
Scarborough General Hospital is leading the way in the fight against infection control by combining traditional infection control techniques with hydrogen peroxide vapour (HPV) bio-decontamination equipment.
Published on 1st March 2012
Hydrogen peroxide vapour technology is confirmed as superior to the aerosolised hydrogen peroxide process following the publication of a recent independent study. A team at St George’s Hospital, London, unquestionably established that hydrogen peroxide vapour (HPV) technology from Bioquell was faster, safer and more effective for biological inactivation than aerosolised hydrogen peroxide (aHP).
Published on 7th February 2012
The latest generation hydrogen peroxide bio-decontamination technology from Bioquell has now achieved Australian C-Tick approval. Targeted at the life science and healthcare markets, this cutting-edge bio-decontamination methodology is used to eradicate microbes from the environment including the problematic hospital ‘superbugs’.